Can levofloxacin (Levaquin) interfere with lithium levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Levofloxacin Interfere with Lithium Levels?

Yes, levofloxacin can increase lithium levels and this interaction is clinically significant, requiring close monitoring of lithium concentrations when these medications are co-administered.

Evidence for the Interaction

The most direct evidence comes from a pharmacokinetic study in rabbits that demonstrated significant increases in lithium levels when levofloxacin was co-administered 1. When a single dose of levofloxacin was given with steady-state lithium, the maximum concentration (Cmax) of lithium increased from 2.54 to 2.79 mmol/L (P < 0.001), and the area under the curve (AUC) increased from 24.36 to 31.88 mmol/mL·h (P < 0.001). The interaction was even more pronounced with repeated levofloxacin dosing—when levofloxacin was given for 3 consecutive days after lithium steady-state was achieved, lithium Cmax increased from 2.72 to 3.96 mmol/L (P < 0.001) and AUC increased from 27.1 to 42.64 mmol/mL·h 1.

A retrospective case-control study examining drug interactions as determinants of elevated lithium levels found that antibiotics, as a class, contributed substantially to elevated lithium concentrations in clinical practice 2. The study reported an odds ratio of 2.70 (95% CI 0.78-9.31) for use of concomitant medication, with antibiotics making a large contribution to this association.

Clinical Significance and Mechanism

Lithium has a narrow therapeutic window (0.6-1.2 mEq/L), and toxicity risk increases substantially at levels above 1.5 mEq/L 3. The mechanism of this interaction likely involves altered renal clearance, as lithium is entirely excreted by the kidneys with approximately 80% reabsorbed in the proximal tubule 3. Any drug that affects renal function or sodium handling can increase lithium levels 3.

Clinical Management Algorithm

When prescribing levofloxacin to a patient on lithium therapy:

  1. Check baseline lithium level before starting levofloxacin
  2. Monitor lithium levels closely during levofloxacin therapy:
    • Check lithium level 2-3 days after starting levofloxacin
    • Check again at day 5-7 if levofloxacin continues
    • More frequent monitoring if baseline lithium level is >1.0 mEq/L
  3. Watch for early signs of lithium toxicity: tremor, drowsiness, muscular weakness, lack of coordination, nausea, vomiting, diarrhea 4
  4. Consider empiric lithium dose reduction of 25-50% when starting levofloxacin, particularly if baseline lithium level is >0.8 mEq/L
  5. Ensure adequate hydration to maintain renal function 5

Important Caveats

  • The interaction appears dose-dependent and duration-dependent, with greater effects seen with repeated levofloxacin dosing 1
  • Patients with reduced renal function (CrCl <50 mL/min) are at higher risk, as both drugs require renal dose adjustment 6, 7
  • The FDA label for levofloxacin does not specifically mention lithium interaction 8, but the lithium FDA label emphasizes that drug interactions can impair elimination and cause toxicity 4
  • Do not assume dietary lithium supplements pose the same risk—one case report showed lithium orotate supplements resulted in undetectable serum lithium levels 9

Alternative Considerations

If possible, consider alternative antibiotics that have less documented interaction with lithium, though the evidence base for fluoroquinolone-lithium interactions specifically is limited. The broader principle is that any medication affecting renal function or sodium balance can alter lithium levels 5.

Related Questions

In a patient with a serum lithium level of 0.8 mmol/L, is it safe to initiate levofloxacin therapy, and should the lithium dose be adjusted or held during treatment?
Can nitrofurantoin affect lithium serum concentrations?
What antibiotic is most likely to interact with lithium in a patient with bipolar affective disorder?
Is it safe to initiate lithium therapy in a patient taking esomeprazole (Nexium) 40 mg twice daily, diltiazem hydrochloride 240 mg daily, meloxicam (Mobic) 7.5 mg daily, atorvastatin 40 mg daily, inhaled fluticasone propionate (Flovent) as needed, fluticasone nasal spray 50 mcg two puffs daily, a rescue inhaler, and testosterone, with controlled hypertension, asthma, acid reflux, and recent glaucoma surgery?
What is the recommended levofloxacin and clindamycin dosing regimen, duration, and monitoring for a patient with acute cellulitis requiring broad‑spectrum coverage?
What surgical options are appropriate for a medically stable patient with chronic lymphedema who has exhausted conservative measures such as compression, manual lymphatic drainage, exercise, and skin care?
Does propranolol decrease heart rate?
Is a 500 mg Zithromax (azithromycin) tablet the complete Z‑Pack regimen?
In a bipolar patient with aripiprazole‑induced akathisia on aripiprazole 15 mg daily, how can I cross‑titrate to lurasidone (Caplyta)?
Can you interpret the laboratory results for a 25-year-old female patient?
What are the nutritional concerns, restrictions, and recommendations for a patient with end‑stage renal disease undergoing dialysis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.